CD4 and neoplasm: Furthermore, the transferred cells remained in metastatic lesions and immunohistochemical analysis revealed that all tumor lesions were MHC class II (MHC-II) negative, suggesting that these CD4+ T cells were not responding directly to the MHC-II deficient tumor cells (10).